Discover
ANVS
Annovis Bio, Inc.
1.14
4400 x 1.13
2500 x 1.16
bid
ask
+
0.04
3.64%
3450 @ 07:30 PM
1.16 +0.02 (1.75%)
| Ytd | -67.05% | |
| 1y | -51.49% |
1.09
day range
1.16
1.04
52 week range
5.50
| Open | 1.12 | Prev Close | 1.10 | Low | 1.09 | High | 1.16 | Mkt Cap | 48.65M |
| Vol | 677.30K | Avg Vol | 921.61K | EPS | -1.75 | P/E | N/A | Forward P/E | -2.77 |
| Beta | 1.24 | Short Ratio | 6.21 | Inst. Own | 8.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.65 | 200-d Avg | 2.32 | 1yr Est | 34.80 |
| Income Statement | |||
| Operating Expenses | 14.38M | ||
| Research and Development Expense | 12.01M | ||
| Selling, General and Administrative Expense | 2.37M | ||
| Operating Income | -14.38M | ||
| Net Income | -14.82M | ||
| Net Income Common Stock | -14.82M | ||
| Net Income Common Stock (USD) | -14.82M | ||
| Consolidated Income | -14.82M | ||
| Earnings per Basic Share | -0.40 | ||
| Earnings per Basic Share (USD) | -0.40 | ||
| Earnings per Diluted Share | -0.40 | ||
| Earning Before Interest & Taxes (EBIT) | -14.82M | ||
| Earning Before Interest & Taxes (USD) | -14.82M | ||
| Weighted Average Shares | 37.52M | ||
| Weighted Average Shares Diluted | 37.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.73M | ||
| Cash and Equivalents (USD) | 18.73M | ||
| Current Assets | 22.04M | ||
| Total Assets | 22.04M | ||
| Current Liabilities | 6.36M | ||
| Total Liabilities | 26.29M | ||
| Accumulated Retained Earnings (Deficit) | -196.13M | ||
| Shareholders Equity | -4.25M | ||
| Shareholders Equity (USD) | -4.25M | ||
| Liabilities Non-Current | 19.93M | ||
| Trade and Non-Trade Payables | 3.33M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 26.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.51M | ||
| Issuance (Purchase) of Equity Shares | 26.42M | ||
| Net Cash Flow from Operations | -21.91M | ||
| Share Based Compensation | 1.61M | ||